Rafael (NYSE:RFL) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen upgraded shares of Rafael (NYSE:RFL - Free Report) to a hold rating in a research report sent to investors on Saturday morning.

Rafael Price Performance

Shares of RFL stock remained flat at $2.21 during mid-day trading on Friday. 101,034 shares of the stock were exchanged, compared to its average volume of 94,227. The firm's 50-day moving average is $1.68 and its 200 day moving average is $1.81. Rafael has a fifty-two week low of $1.28 and a fifty-two week high of $3.19. The stock has a market cap of $77.55 million, a price-to-earnings ratio of -2.35 and a beta of 0.97.

Rafael (NYSE:RFL - Get Free Report) last issued its earnings results on Wednesday, June 11th. The company reported ($0.19) EPS for the quarter. Rafael had a negative net margin of 3,127.60% and a negative return on equity of 24.75%. The business had revenue of $0.36 million during the quarter.

Insider Transactions at Rafael

In other news, CEO Howard S. Jonas purchased 13,080,457 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average price of $1.28 per share, with a total value of $16,742,984.96. Following the purchase, the chief executive officer directly owned 12,299,207 shares of the company's stock, valued at approximately $15,742,984.96. This represents a -1,674.30% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 10.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Rafael

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RFL. Wealth Enhancement Advisory Services LLC purchased a new stake in Rafael during the 1st quarter worth $26,000. Geode Capital Management LLC increased its position in shares of Rafael by 17.9% in the 4th quarter. Geode Capital Management LLC now owns 174,561 shares of the company's stock worth $288,000 after purchasing an additional 26,493 shares during the last quarter. Finally, Ieq Capital LLC bought a new stake in shares of Rafael in the 1st quarter worth about $447,000. Hedge funds and other institutional investors own 11.30% of the company's stock.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.